Medication Management P&T committee and formulary management
description
Transcript of Medication Management P&T committee and formulary management
![Page 1: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/1.jpg)
MEDICATION MANAGEMENT
P&T COMMITTEE AND FORMULARY MANAGEMENT
EMTENAN ALHARBI, Msc
CLINICAL PHARMACIST
![Page 2: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/2.jpg)
Learning Objectives
Discuss the organization and role of the pharmacy and therapeutic committee .
Explain how formulary management works.
![Page 3: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/3.jpg)
Introduction
Medication use management describe the process used to assure the safe and effective use of drugs in a cost conscious manner.
The key to medication management is the formulary system.
![Page 4: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/4.jpg)
Formulary system
Formulary system defined as an ongoing process which methodically evaluate medications for inclusion\exclusion, establishing guidelines and developing policy and procedures.
The formulary system is managed by pharmacy and therapeutic committee.
![Page 5: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/5.jpg)
Pharmacy and Therapeutic committee(P&T committee)
![Page 6: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/6.jpg)
P&T committee-definition
P &T committee is a group responsible for overseeing all aspects of drug therapy in an institution.
Because drug products and medical literature are continually changing ,meeting should occur at lease 4-6 times per year.
Generally , monthly meetings are needed to keep the meeting time to 60-90 minutes.
![Page 7: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/7.jpg)
P&T committee-definition
![Page 8: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/8.jpg)
P&T committee membership
![Page 9: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/9.jpg)
P&T committee membership
Therefore, Medication management is a multidisciplinary process.
The voting members of the P&T committee in many hospitals remains to physicians only. this is changing as the committee membership is evolving.
![Page 10: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/10.jpg)
P&T committee-responsibilities
![Page 11: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/11.jpg)
Formulary system maintenance
The committee develop a list of medication for use on regular basis to assure that the current need of patents and staff are met.
They also develop guidelines for the optimal use of medication for specific disease management.
![Page 12: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/12.jpg)
Medication selection and review
A written medication review is prepared from available literature.
The review should be unbiased, and committee members should discuss any conflict of interest prior to discussion of drug or drug class.
Medication selection criteria should be based on efficacy, safety and cost.
![Page 13: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/13.jpg)
Medication selection and review
Other issues that should be considered in medication selection process such as duplication, method of administration and targeted population.
Barriers to optimal formulary decision include :
1. physicians experience and preference.2. detailing by pharmaceutical company
representatives.
![Page 14: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/14.jpg)
Medication use evaluation (MUE) MUE is the method for evaluating and
improving medication use process with the goal of optimal patient outcome.
Medication considered for review are based on efficacy ,safety and cost or a combination of factors.
E.g. antibiotics
![Page 15: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/15.jpg)
Medication safety evaluation
Medication safety is evaluated through ADRs and medication errors reports.
Such reports may be local i.e SFDA or global i.e literature or press release.
![Page 16: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/16.jpg)
Drug therapy guidelines
Are listing of the indications, dosage regimen, duration, route of administration ,monitoring parameter and special consideration.
These guidelines are often put into via pre-printed physician order sheet placed in the patient chart .
![Page 17: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/17.jpg)
Policy& procedure development
Guidelines development on pharmacy related topics such as narcotics ,IV preparation and chemotherapy handling .
![Page 18: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/18.jpg)
Education
Newsletters are often employed to include clinical information on drug added to the formulary, medication safety alerts and new guidelines.
The newsletter should be visually pleasing, easy to follow and limited to 2-4 pages.
Presentations are also employed to educate staff and awareness days are held to educate patients.
![Page 19: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/19.jpg)
Formulary management
![Page 20: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/20.jpg)
Formulary management
![Page 21: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/21.jpg)
Formulary restrictions
Do not necessarily translate to optimal medication management.
Some authors suggested that restricting formularies has resulted in increased health care cost and hospitalization i.e. antimicrobial resistance.
![Page 22: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/22.jpg)
Therapeutic equivalent and interchange
Drug products with different chemical structure and same pharmacological \therapeutic use
E.g. 1st generation cephalosporin.
Histamine -2 blocker.
Is the authorized exchange of therapeutic alternative in accordance to previously established guidelines. This should include dose strength ,frequency and route.
E.g. cimetdine 300 mg q 6 hour is as effective as ranitidine 50 mg q 8 hours.
Therapeutic equivalent Therapeutic interchange
![Page 23: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/23.jpg)
Formulary maintenance
New product evaluation. Non-formulary drug use review.
![Page 24: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/24.jpg)
New product evaluation
Development of slandered format for new drug evaluation is useful in facilitating P&T committee discussions.
The slandered element include the following:
Generic name Indication\uses
Trade name Adverse events
Pharmacological class Drug interaction
Pharmacology Dosing
Pharmacokinetics Cost
Clinical studies Summary, recommendation and references .
leuprolide acetate
![Page 25: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/25.jpg)
Non-formulary drug use review Unique patients needs may require the
use of non-formulary agent. the process includes the completion of
non-formulary request form by the prescribing physician.
This may take up to 24 hours delivery time. it also permit the use of patient own medications.
![Page 26: Medication Management P&T committee and formulary management](https://reader035.fdocuments.us/reader035/viewer/2022062809/5681591d550346895dc6447a/html5/thumbnails/26.jpg)
Non-formulary drug use review P&T committee frequently assess the
non-formulary requests .critical information such number of times used in the last 6-12 months, patient safety and cost should be considered.
Understanding this information will allow the committee to take an action plan such as reconsidering the agent for formulary addition or adding the drug with restrictions.